Bruce Jenett focuses his practice on the representation of US and international business and finance clients in the life sciences industry.

He is highly experienced in equity and debt financing, licensing and distribution, strategic alliances, joint ventures, and mergers and acquisitions, as well as general counseling issues, representing both startups and large multinational corporations. Bruce has, for example, represented clients in one of the largest (in financial terms) ag-bio partnering deals in history, and one of the largest (also in financial terms) partnering deals done by an Irish venture capital-backed biotechnology company with a major pharmaceutical company. Abingworth Management, Inc., Astellas Venture Capital LLC, Bayer Corporation and Bayer AG, CardioGenesis Corporation, Exelixis, Inc., IntegenX Inc., Intellikine, Inc., Novo Ventures (US), Inc., OptiMedica Corporation, TPG Ventures, VisionCare Ophthalmic Technologies, Inc., and several startup incubators have been among his clients.